New hope from a 40-year-old drug: deaths from heart failure cut by 30 percent.
Comarow
A
A
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004232:Diuretics / Q000627:therapeutic use*; D017277:Drug Approval; D006266:Health Education; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D013148:Spironolactone / Q000627:therapeutic use*; D014481:United States
D000806:Angiotensin-Converting Enzyme Inhibitors; D004232:Diuretics; D013148:Spironolactone